All Posts By

Smartkarma Daily Briefs

Macro: BoE Pressure Eases With Expectations and more

By | Daily Briefs, Macro

In today’s briefing:

  • BoE Pressure Eases With Expectations
  • CX Daily: How Law Professors Take Turns to Serve China’s Courts

BoE Pressure Eases With Expectations

By Phil Rush

  • The BoE warned it would hike more aggressively if inflation pressures became more persistent. Market pricing levels and responsiveness have fallen, relaxing that pressure.
  • Consumers are baulking at price rises to the extent that businesses are starting to curb their expectations for future price rises.
  • Wage settlements appear to have at least topped out and, with rising unemployment, are consistent with the cycle burning out soon. The BoE should not raise its hiking pace.

CX Daily: How Law Professors Take Turns to Serve China’s Courts

By Caixin Global

  • Scholars / In Depth: How law professors take turns to serve China’s courts

  • Forum / China, U.S. urged to manage ‘cutthroat’ competition and avoid war over Taiwan

  • Flu / Flu epidemic sweeps South China as Covid wanes


Before it’s here, it’s on Smartkarma

Equity Bottom-Up: New Oriental Education & Technology Group, DoorDash Inc, Xperi, Delta Electronics Thai, Medy Tox Inc and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • A New New Oriental?
  • Amazon’s Grubhub Deal Worse for DoorDash than Uber
  • XPER: Positive Catalyst to Growth Story
  • DELTA: Shortage Issue Still Persists Despite Concerns on Weakening Demand in 2022
  • Medy Tox Inc (086900 KS): Legal Battle Continues; Muted Recovery in Export Revenue

A New New Oriental?

By Evelyn Zhang

  • Oriental Selection achieves high-speed user growth through bilingual livestreaming, thanks to Douyin’s  algorithmic recommendation mechanism before 6/18 ecommerce, after 6/18 the increase in the follower numbers & GMV dropped sharply.
  • The unit price of the product is below average, due to the focus on produce and books, Agricultural livestreaming has always been a difficult to grow category
  • 10%-15% Commission  is lower than industry average, and subsequent supply chain control and 1st party products have lower margins.

Amazon’s Grubhub Deal Worse for DoorDash than Uber

By Aaron Gabin

  • Amazon announced a partnership with TKWY’s Grubhub where Amazon Prime members will get one year free of Grubhub+ membership.
  • Amazon has the option to take a 2% stake in Grubhub which could grow to 15% depending on performance conditions.
  • Deal is a direct shot at DoorDash’s Dashpass subscription program, which is 30% of DASH’s customers and accounts for ~50%? of GOV… expect a price cut to stave off churn.

XPER: Positive Catalyst to Growth Story

By Hamed Khorsand

  • XPER is accelerating its presence within connected TVs with the acquisition of Vewd Software
  • Vewd Software is a middleware developer that has been installed in more than 450 million connected TVs and devices.
  • The synergistic value of Vewd could be revealed to shareholders in the next 12 to 18 months when XPER begins to monetize Vewd’s install base

DELTA: Shortage Issue Still Persists Despite Concerns on Weakening Demand in 2022

By Pi Research

  • We maintain our BUY rating and TP of Bt419 based on based on 51.7xPE’22E. Business update meeting last Friday came with positive news on improving shortage situation by 4Q22 
  • 2Q22E earnings to decline QoQ: We believe that 2Q22E net profit will be at Bt2.7bn (+61% YoY, -4% QoQ).
  • We expect 2Q22E sales to be at Bt24bn (+15%YoY, -4% QoQ). QoQ decline is mainly due to lockdown issues in China and longer holidays during 2Q22.

Medy Tox Inc (086900 KS): Legal Battle Continues; Muted Recovery in Export Revenue

By Tina Banerjee

  • The U.S. International Trade Commission is starting an official investigation based on Medy Tox Inc (086900 KS)’s complaint against Hugel for the alleged theft of its botulinum toxin strain.  
  • The verdict is expected in H12023. Hugel is expected to receive FDA approval for botulinum toxin by the end of 2022, while Medytox plans to file to FDA in H12023.  
  • Medytox’s export revenue has still not recovered. However, Q1 sales jumped 25%, on the back of 89% increase in domestic revenue. Medytox shares has declined 20% YTD.

Related tickers: Xperi (TSRA.O), Delta Electronics Thai (DELTA.BK), Medy Tox Inc (086900.KQ)

Before it’s here, it’s on Smartkarma

South Korea: SK IE Technology, LG Energy Solution, HPSP, Medy Tox Inc and more

By | Daily Briefs, South Korea

In today’s briefing:

  • SKIET Block Deal: Passive Impact on TIGER (WISE) Secondary Cell ETF Rebalancing
  • LG Energy Solution: Potential Sellers Post Lock-Up End, Mkt Share Losses, & LG Chem’s Capital Needs
  • HPSP IPO Book Building Results Analysis
  • Medy Tox Inc (086900 KS): Legal Battle Continues; Muted Recovery in Export Revenue

SKIET Block Deal: Passive Impact on TIGER (WISE) Secondary Cell ETF Rebalancing

By Sanghyun Park

  • This block deal won’t lead to a float increase event. Nevertheless, it will substantially impact the rebalancing of the TIGER (WISE) Secondary Cell ETF next week.
  • A passive net inflow of up to ₩10B occurs, equivalent to 0.5x ADTV. Indeed, this level provides a significant day trade setup.
  • With today’s price correction, SKIET’s index weight will drop to the high 4% range. Applying the 36% float to today’s price will increase the weight to 5.5% at the rebalancing. 

LG Energy Solution: Potential Sellers Post Lock-Up End, Mkt Share Losses, & LG Chem’s Capital Needs

By Douglas Kim

  • Although LG Chem may not sell additional stake in LGES this year, over the next 2-3 years, there is a high probability of LG Chem selling some stake in LGES.
  • On 27 July 2022, 86% stake of LG Energy Solution could be sold, of which 81.8% is owned by LG Chem and the remaining 4.2% is owned by institutional investors/others.
  • LGES’s market share in the global rechargeable battery usage declined significantly from May 2021 to May 2022, due to recent EV disruption at Tesla’s Shanghai plant and rise of BYD.

HPSP IPO Book Building Results Analysis

By Douglas Kim

  • HPSP (403870 KS) announced its IPO book building results. The IPO price has been determined at 25,000 won, which is at the high end of the IPO price range.
  • There were 1,577 institutions that were involved in the IPO survey and the demand ratio was 1,511 to 1. The IPO offering amount is 75 billion won.
  • Our base case valuation of HPSP is target price of 38,228 won per share, which represents 53% higher than the high end of the IPO price range of 25,000 won.

Medy Tox Inc (086900 KS): Legal Battle Continues; Muted Recovery in Export Revenue

By Tina Banerjee

  • The U.S. International Trade Commission is starting an official investigation based on Medy Tox Inc (086900 KS)’s complaint against Hugel for the alleged theft of its botulinum toxin strain.  
  • The verdict is expected in H12023. Hugel is expected to receive FDA approval for botulinum toxin by the end of 2022, while Medytox plans to file to FDA in H12023.  
  • Medytox’s export revenue has still not recovered. However, Q1 sales jumped 25%, on the back of 89% increase in domestic revenue. Medytox shares has declined 20% YTD.

Before it’s here, it’s on Smartkarma

Thailand: Advanced Info Service, Jasmine Broadband Internet Infrastructure Fund and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Jasmine Acquisition To Expand Advanced’s Broadband Footprint
  • JASIF : Contract Cancellation Will Affect Dividend Payment
  • ADVANC : Large Boost to Broadband Business Growth
  • Advanced Info Service (ADVANC.BK) – Return Of Roaming Fees

Jasmine Acquisition To Expand Advanced’s Broadband Footprint

By David Blennerhassett


JASIF : Contract Cancellation Will Affect Dividend Payment

By Pi Research

  • Downgrade to HOLD fom BUY and cut TP by 28% to Bt8.80 derived form DCF (WACC=8.02%, g=0%) to factor in significant reduction in revenue and dividend from 2023 
  • A non-attractive deal for JASIF shareholders: On July 4th 2022, JAS informed SET that, ADVANC is considering purchase of 99.99% of TTTBB and 19% of total JASIF units at Bt8.5 
  • In that case,The Amended Rental Assurance agreement that generates a superior rental rate of770/km/month will be cancelled which will cause a dip of 30%in the revenue generation of JASIF in2023onwards.

ADVANC : Large Boost to Broadband Business Growth

By Pi Research

  • We maintain our BUY rating and TP of Bt259 based on based on DCF,representing 26.4xPE’22E. Analyst meeting yesterday on ADVANC’s acquisition of TTTBB and JASIF units came with positive tone
  • The deal should be highly favorable for ADVANC:We believe that the entire transaction could provide a 8.5% upside to our current forecasted 23E EPS through Adjusted EPS, leading to Bt11.54/share.
  • 2Q22E earnings will keep 22E earnings on track We believe that 2Q22E net profit will be at Bt6.5bn(-7% YoY, +4% QoQ).Seasonal low costs, despite high competition, will lead to QoQ 

Advanced Info Service (ADVANC.BK) – Return Of Roaming Fees

By Maybank Research

  • 2Q22E performance to recover thanks to tourists
  • 2Q22E core net profit to recover YoY and QoQ
  • Tourists to the rescue
  • ADVANC (BUY, THB230 TP) remains our Top Pick

Before it’s here, it’s on Smartkarma

Health Care: Shionogi & Co, Gaush Meditech and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Shionogi & Co (4507 JP): Ready To Cash-In On COVID-Related Efforts; Long-Term Growth Drivers Added
  • Pre-IPO Gaush Meditech – The “Middlemen” Have Many Challenges

Shionogi & Co (4507 JP): Ready To Cash-In On COVID-Related Efforts; Long-Term Growth Drivers Added

By Tina Banerjee

  • Shionogi & Co (4507 JP), an established global name in infectious diseases, is banking on COVID-related products to achieve accelerated double-digit revenue growth in current fiscal.
  • Shionogi applied for the domestic marketing of its COVID-19 oral drug and signed a basic agreement with the government, which is expected to purchase 1 million courses immediately after approval.
  • It has a stable revenue stream from HIV franchise. Apart from infectious diseases, Shionogi has multiple late-stage candidates in psycho-neurological diseases and other new growth areas, including oncology and cardiology.

Pre-IPO Gaush Meditech – The “Middlemen” Have Many Challenges

By Xinyao (Criss) Wang

  • Gaush Meditech (GMT HK) is a leading total solution provider of ophthalmic medical devices industry.
  • The irreplaceability of Gaush in the whole industrial chain is actually not high based on its current business model.The proprietary product business may also need to face different policy risks.
  • Together with other uncertainties such as increasing market competition and medical reform policy in China, we are conservative about Gaush’s outlook at the current stage.  

Before it’s here, it’s on Smartkarma

Financials: Tokyo Stock Exchange Tokyo Price Index Topix, Jasmine Broadband Internet Infrastructure Fund, Bitcoin and more

By | Daily Briefs, Financials

In today’s briefing:

  • Are Japanese Stocks Undervalued or Is There a Reason for Stagnant Valuations?
  • JASIF : Contract Cancellation Will Affect Dividend Payment
  • BTC Drops Below $20k as Credit Contagion Spreads

Are Japanese Stocks Undervalued or Is There a Reason for Stagnant Valuations?

By Aki Matsumoto

  • I would like to discuss the Nikkei article on “Stock market interest is shifting to undervalued stocks, but analyst coverage of small- and mid-cap stocks is scarce.”
  • Assuming investors don’t buy a stock because it’s cheap, but because they understand the gap between its intrinsic value and the share price, to make many investors understand the value.
  • Companies are required to execute capital allocations and communicate with analysts and investors to increase corporate value, and those that were able to do so were able to raise valuations.

JASIF : Contract Cancellation Will Affect Dividend Payment

By Pi Research

  • Downgrade to HOLD fom BUY and cut TP by 28% to Bt8.80 derived form DCF (WACC=8.02%, g=0%) to factor in significant reduction in revenue and dividend from 2023 
  • A non-attractive deal for JASIF shareholders: On July 4th 2022, JAS informed SET that, ADVANC is considering purchase of 99.99% of TTTBB and 19% of total JASIF units at Bt8.5 
  • In that case,The Amended Rental Assurance agreement that generates a superior rental rate of770/km/month will be cancelled which will cause a dip of 30%in the revenue generation of JASIF in2023onwards.

BTC Drops Below $20k as Credit Contagion Spreads

By Kaiko

  • Trend of the Week: Tether’s market cap has plummeted amid a reportedly sharp increase in bearish bets.
  • Price Movements: BTC dipped below $20k while ETH held steady above $1k as credit contagion continued to roil markets.
  • Market Liquidity: Binance.US processed a record number of transactions after eliminating BTC trading fees.

Before it’s here, it’s on Smartkarma

Most Read: Powerchip Semiconductor Manufacturing Corp, Kasikornbank PCL, SPH REIT, SK IE Technology, Tianqi Lithium and more

By | Daily Briefs, Most Read

In today’s briefing:

  • FTSE All-World/​​​All-Cap Sep Index Rebalance Preview: Asia Ex Japan Ex China
  • Kasikornbank (KBANK TB): Potential MSCI Inclusion
  • SPH REIT Float Drops – Index Impacts To Come (Today and Beyond)
  • SK IE Technology Placement – Last Deal Didn’t Do Well, More Discount and Cleanup Should Help
  • MSCI August 2022 Index Rebalance Preview: The Last QIR?

FTSE All-World/​​​All-Cap Sep Index Rebalance Preview: Asia Ex Japan Ex China

By Brian Freitas

  • The price review period for the FTSE All-World/All-Cap September 2022 SAIR ended on 30 June. The changes are expected to be announced on 19 August and implemented on 16 September.
  • For Asia ex-Japan ex-China, we see 7 inclusions to All-World, 58 inclusions to All-Cap, 9 migrations from All-Cap to All-World, 5 migrations from All-World to All-Cap, and 20 deletions.
  • There are quite a few names in Australia that could have same way flows from the S&P/ASX 200 and S&P/ASX 300 Index trackers on the same day as the FTSE trackers.

Kasikornbank (KBANK TB): Potential MSCI Inclusion

By Brian Freitas

  • Kasikornbank PCL (KBANK-R TB) was deleted from the MSCI Thailand Index in June 2021 following the issuance of NVDR’s approaching its permitted limit of 25% of issued shares.
  • With 12 months since deletion complete and meeting market cap, liquidity and foreign room thresholds, Kasikornbank PCL (KBANK TB) could be added to the MSCI Thailand Index in August.
  • If added to the MSCI Thailand Index, we estimate passive trackers will need to buy 47.39m shares (US$199m; 3.9 days of ADV) of Kasikornbank PCL (KBANK TB) on 31 August.

SPH REIT Float Drops – Index Impacts To Come (Today and Beyond)

By Travis Lundy


SK IE Technology Placement – Last Deal Didn’t Do Well, More Discount and Cleanup Should Help

By Sumeet Singh

  • SK IE Technology’s (SKIE) shareholder aims to raise around US$228m via selling their remaining shareholding.
  • The same shareholder had sold some of their stake earlier in Nov 21. That deal didn’t end up doing well.
  • In this note, we will talk about the deal dynamics and  run the deal through our ECM framework.

MSCI August 2022 Index Rebalance Preview: The Last QIR?

By Brian Freitas


Before it’s here, it’s on Smartkarma

Equity Capital Markets: SK IE Technology, Emperador Inc, Gaush Meditech, Weilong Delicious Global and more

By | Daily Briefs, ECM

In today’s briefing:

  • SK IE Technology Placement – Last Deal Didn’t Do Well, More Discount and Cleanup Should Help
  • Emperador Secondary Listing – Driven by Whisky, Supported by Brandy
  • Pre-IPO Gaush Meditech – The “Middlemen” Have Many Challenges
  • Weilong Delicious Global Pre-IPO – Growth Is Slowing but Pre-IPO Valuation Has Been Halved

SK IE Technology Placement – Last Deal Didn’t Do Well, More Discount and Cleanup Should Help

By Sumeet Singh

  • SK IE Technology’s (SKIE) shareholder aims to raise around US$228m via selling their remaining shareholding.
  • The same shareholder had sold some of their stake earlier in Nov 21. That deal didn’t end up doing well.
  • In this note, we will talk about the deal dynamics and  run the deal through our ECM framework.

Emperador Secondary Listing – Driven by Whisky, Supported by Brandy

By Sumeet Singh

  • Emperador (Emp) is looking to raise up to US$750m via a secondary listing in Singapore.
  • Emp is the Philippines’ largest liquor company and the world’s largest brandy producer. Its products are sold in over 100 countries.
  • In this note, we look at the company’s past performance.

Pre-IPO Gaush Meditech – The “Middlemen” Have Many Challenges

By Xinyao (Criss) Wang

  • Gaush Meditech (GMT HK) is a leading total solution provider of ophthalmic medical devices industry.
  • The irreplaceability of Gaush in the whole industrial chain is actually not high based on its current business model.The proprietary product business may also need to face different policy risks.
  • Together with other uncertainties such as increasing market competition and medical reform policy in China, we are conservative about Gaush’s outlook at the current stage.  

Weilong Delicious Global Pre-IPO – Growth Is Slowing but Pre-IPO Valuation Has Been Halved

By Sumeet Singh

  • Weilong Delicious Global (WDG), a spicy snack food company in China, aims to raise around US$500m in its Hong Kong IPO.
  • According to F&S, WDG ranked first among spicy snack food enterprises in China, with a market share of 6.2%, and in the seasoned flour product and spicy vegetable snacks categories.
  • In this note, we talk about the updates from its refiled PHIP.

Before it’s here, it’s on Smartkarma

China: Tianqi Lithium, SenseTime Group, West China Cement, China Power International, Gaush Meditech, Weilong Delicious Global, Hopson Development and more

By | China, Daily Briefs

In today’s briefing:

  • MSCI August 2022 Index Rebalance Preview: The Last QIR?
  • SenseTime: Shares Fall with Lock-Up Expiry; Further Downside with More Selling at the Next Expiry
  • West China Cement – Tear Sheet – Lucror Analytics
  • China Power International (2380 HK): Another Step in Clean Energy Transition
  • Pre-IPO Gaush Meditech – The “Middlemen” Have Many Challenges
  • Weilong Delicious Global Pre-IPO – Growth Is Slowing but Pre-IPO Valuation Has Been Halved
  • Morning Views Asia: Hopson Development, KWG Living Group, Powerlong Commercial Management Holdings

MSCI August 2022 Index Rebalance Preview: The Last QIR?

By Brian Freitas


SenseTime: Shares Fall with Lock-Up Expiry; Further Downside with More Selling at the Next Expiry

By Shifara Samsudeen, ACMA, CGMA

  • AI software company SenseTime’s share price dropped more than 50% over the last one week with the expiry of lock-up period as pre-investors of the company took some profits.  
  • The company was placed in an investment blacklist by the US government prior to the IPO which forced to launch the IPO without investors from the US.
  • The company also priced the IPO at the bottom of the price range and despite all of this, shares quickly went up to HK$8.20 from IPO price of US$3.85.

West China Cement – Tear Sheet – Lucror Analytics

By Leonard Law, CFA

We view West China Cement (WCC) as “Medium Risk” on the LARA scale. The company has a leading market position in Shaanxi in China, as well as a small but expanding presence in Xinjiang and Guizhou. It also has a plant in Mozambique, which commenced operations in December 2020. The cement industry in Shaanxi has favourable supply/demand dynamics, as producers have been able to coordinate production cuts to boost ASP despite overcapacity. That said, there could be event risks related to WCC’s expansion plans, particularly in Africa (where industry trends are less well-understood). Moreover, the company may be exposed to geopolitical and execution risks in frontier markets.

Our fundamental Credit Bias on WCC is “Stable”, on account of its strong OCF and still-healthy leverage. That said, we believe leverage will weaken in FY 2022 and FY 2023 before recovering, given the company’s plans for continued investments in Africa. Moreover, WCC’s new plants in Africa would require time to ramp up before they can generate meaningful earnings.

Controversies are “Immaterial”. We note that cement production is a major source of carbon emissions. According to IEA, the cement industry contributes 7% of global CO2 emissions and is the second-largest industrial emitter (behind the iron and steel industry). That said, there is a lack of suitable alternatives for cement as an input of concrete. Moreover, WCC’s main markets (China and Africa) will likely remain heavily dependent on cement for infrastructure developments. Hence, we assess the ESG Impact on Credit as “Neutral”. 


China Power International (2380 HK): Another Step in Clean Energy Transition

By Osbert Tang, CFA

  • China Power International (2380 HK) will acquire 2.15GW clean energy capacity from its parent SPIC for a total of Rmb7.5bn. This will add 14.3% to its end-FY21 clean energy portfolio.
  • We think the assets are priced attractively at 12.5x PER for FY21, a discount to peers’ average of 14x. The acquired capacity has an impressive 45.8% YoY earnings growth.
  • CPI targets to have 70% of end-FY23 capacity from clean energy, and this implies a 46.3% CAGR between FY21 and FY23, which is a very exciting momentum. 

Pre-IPO Gaush Meditech – The “Middlemen” Have Many Challenges

By Xinyao (Criss) Wang

  • Gaush Meditech (GMT HK) is a leading total solution provider of ophthalmic medical devices industry.
  • The irreplaceability of Gaush in the whole industrial chain is actually not high based on its current business model.The proprietary product business may also need to face different policy risks.
  • Together with other uncertainties such as increasing market competition and medical reform policy in China, we are conservative about Gaush’s outlook at the current stage.  

Weilong Delicious Global Pre-IPO – Growth Is Slowing but Pre-IPO Valuation Has Been Halved

By Sumeet Singh

  • Weilong Delicious Global (WDG), a spicy snack food company in China, aims to raise around US$500m in its Hong Kong IPO.
  • According to F&S, WDG ranked first among spicy snack food enterprises in China, with a market share of 6.2%, and in the seasoned flour product and spicy vegetable snacks categories.
  • In this note, we talk about the updates from its refiled PHIP.

Morning Views Asia: Hopson Development, KWG Living Group, Powerlong Commercial Management Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

Singapore: SPH REIT, Mapletree Commercial Trust and more

By | Daily Briefs, Singapore

In today’s briefing:

  • SPH REIT Float Drops – Index Impacts To Come (Today and Beyond)
  • MCT SP as MPACT Creeping Ever Higher Vs Peers

SPH REIT Float Drops – Index Impacts To Come (Today and Beyond)

By Travis Lundy


MCT SP as MPACT Creeping Ever Higher Vs Peers

By Travis Lundy

  • Mapletree Commercial Trust (MCT SP) has crept higher vs the Peer Baskets, especially in the last 4-6 weeks as Other S-REITs have weakened. 
  • This sets the stage for a potentially large flowback into S-REITs as a class coming in a few weeks.
  • It may be time to reconsider positioning, looking at where MPACT has been and will be.

Before it’s here, it’s on Smartkarma